Eva Holtved
Aabenraa, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Challenges and solutions across sectors in multi-dose drug dispensing.
Journal: Danish medical journal
Published: April 14, 2026
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 06, 2026
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
Journal: The New England journal of medicine
Published: February 02, 2022
Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 27, 2021
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 25, 2021
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 31, 2020
Percutaneous vertebroplasty as treatment of malignant vertebral lesions: a systematic review and GRADE evaluation resulting in a Danish national clinical guideline.
Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
Published: January 23, 2020
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: July 31, 2019
Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction.
Journal: Cancer treatment and research communications
Published: March 18, 2019
Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 26, 2017
Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer.
Journal: Anticancer research
Published: February 07, 2016
Last Updated: 09/26/2026